It is widely used as a chiral ligand in asymmetric catalysis, particularly in hydrogenation reactions. Its application is crucial in the synthesis of enantiomerically pure compounds, which are essential in the pharmaceutical industry for producing drugs with high stereochemical purity. The ligand's unique structure, combining ferrocene and phosphine groups, enhances its ability to induce high enantioselectivity in catalytic processes. This makes it valuable for the production of chiral intermediates used in the development of active pharmaceutical ingredients (APIs). Additionally, it is employed in the fine chemicals industry for the preparation of specialty chemicals requiring precise stereochemical control. Its stability and efficiency in catalytic systems contribute to its preference in industrial and academic research settings.